Maria Antonella Ruffino
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Maria Antonella Ruffino has a total of 26 co-authors. Here are the top co-authors by number of shared publications:
- Alessandro Robaldo
Division of Vascular Surgery and Angiology, Centro Vascolare Ticino, Ente Ospedaliero Cantonale, 6900 Lugano, Switzerland
4 shared publications - Francesco Andreoli
Division of Vascular Surgery and Angiology, Centro Vascolare Ticino, Ente Ospedaliero Cantonale, CH-6900 Lugano, Switzerland
4 shared publications - Giorgio Prouse
Division of Vascular Surgery and Angiology, Centro Vascolare Ticino, Ente Ospedaliero Cantonale, 6900 Lugano, Switzerland
4 shared publications - Andrea Leoncini
Clinic for Radiology, Imaging Institute of Southern Switzerland, Ente Ospedaliero Cantonale (EOC), Bellinzona, Switzerland
2 shared publications - Elias Wasseh
Faculty of Biomedical Science, Università della Svizzera Italiana (USI), 6900 Lugano, Switzerland
2 shared publications - Fabio Mattiussi
Imaging Institute of Southern Switzerland (IIMSI), Ente Ospedaliero Cantonale (EOC), 6900 Lugano, Switzerland
2 shared publications
Latest Publications
- Open Access
- 9 July 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (14) , 5364
Impact of Postoperative Antithrombotic Treatment on Patency and Survival After Open Posterior Popliteal Artery Aneurysm Repair: A Multicenter Retrospective Cohort Analysis from the PARADE Study
Background/Objectives: This study assessed the impact of different postoperative antithrombotic strategies on graft patency and overall survival after open posterior repair of popliteal artery aneurysms (PAAs). Methods: A retrospectively maintained dataset of consecutive PAAs electively treated in 40 centers between January 2010 and December 2023 was analyzed. The study included patients undergoing elective open posterior repair. Primary outcomes were primary patency and overall survival according to postoperative antiplatelet or anticoagulant therapy. Secondary outcomes included secondary patency and major adverse cardiovascular events (MACEs). Kaplan–Meier analysis, log-rank testing, and Cox regression models were applied. Results: Overall, 638 patients were included. The cohort was predominantly male (96%), with a median age of 70 years. At 30 days, one death (0.2%) and seven MACEs (1.1%) occurred. Postoperative therapy was not associated with 30-day primary patency or MACEs. At a median follow-up of 30 months, overall survival was 90.3%. Kaplan–Meier analysis showed comparable overall survival across antithrombotic regimens, with a significant difference observed only between patients receiving combined anticoagulant and antiplatelet therapy and those receiving other regimens (p = 0.018). No differences emerged between vitamin K antagonists (VKAs) and direct oral anticoagulants (DOACs), nor between single or dual antiplatelet therapy and anticoagulation. Multivariable Cox regression showed that combined therapy was associated with poorer overall survival compared with other postoperative antithrombotic regimens (CT vs. others: HR of 1.30). Primary and secondary patency were also similar among regimens except for combined therapy (primary patency: p = 0.004; secondary patency: p = 0.018). Conclusions: Postoperative medical therapy was not associated with 30-day outcomes. During long-term follow-up, overall survival and graft patency were lower in patients receiving combined anticoagulant and antiplatelet therapy. Bleeding outcomes were not captured in this registry; as bleeding may contribute to the worse outcomes observed with combined therapy, this represents an important limitation.
- 9 July 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (14) , 5364
Open AccessImpact of Postoperative Antithrombotic Treatment on Patency and Survival After Open Posterior Popliteal Artery Aneurysm Repair: A Multicenter Retrospective Cohort Analysis from the PARADE Study
Background/Objectives: This study assessed the impact of different postoperative antithrombotic strategies on graft patency and overall survival after open posterior repair of popliteal artery aneurysms (PAAs). Methods: A retrospectively maintained dataset of consecutive PAAs electively treated in 40 centers between January 2010 and December 2023 was analyzed. The study included patients undergoing elective open posterior repair. Primary outcomes were primary patency and overall survival according to postoperative antiplatelet or anticoagulant therapy. Secondary outcomes included secondary patency and major adverse cardiovascular events (MACEs). Kaplan–Meier analysis, log-rank testing, and Cox regression models were applied. Results: Overall, 638 patients were included. The cohort was predominantly male (96%), with a median age of 70 years. At 30 days, one death (0.2%) and seven MACEs (1.1%) occurred. Postoperative therapy was not associated with 30-day primary patency or MACEs. At a median follow-up of 30 months, overall survival was 90.3%. Kaplan–Meier analysis showed comparable overall survival across antithrombotic regimens, with a significant difference observed only between patients receiving combined anticoagulant and antiplatelet therapy and those receiving other regimens (p = 0.018). No differences emerged between vitamin K antagonists (VKAs) and direct oral anticoagulants (DOACs), nor between single or dual antiplatelet therapy and anticoagulation. Multivariable Cox regression showed that combined therapy was associated with poorer overall survival compared with other postoperative antithrombotic regimens (CT vs. others: HR of 1.30). Primary and secondary patency were also similar among regimens except for combined therapy (primary patency: p = 0.004; secondary patency: p = 0.018). Conclusions: Postoperative medical therapy was not associated with 30-day outcomes. During long-term follow-up, overall survival and graft patency were lower in patients receiving combined anticoagulant and antiplatelet therapy. Bleeding outcomes were not captured in this registry; as bleeding may contribute to the worse outcomes observed with combined therapy, this represents an important limitation.
- Open Access
- 12 May 2026
- Published by MDPI AG in Preprints.org
Impact of Postoperative Antithrombotic Treatment on Patency and Survival After Open Posterior Popliteal Artery Aneurysm Repair: A Multicenter Retrospective Cohort Analysis from the PARADE Study
Background/Objectives: This study assessed the impact of different postoperative antithrombotic strategies on graft patency and overall survival after open posterior repair of popliteal artery aneurysms (PAAs). Methods: A retrospectively maintained dataset of consecutive PAAs electively treated in 40 centers between January 2010 and December 2023 was analyzed. The study included patients undergoing elective open posterior repair. Primary outcomes were primary patency and overall survival according to postoperative antiplatelet or anticoagulant therapy. Secondary outcomes included secondary patency and major adverse cardiovascular events (MACEs). Kaplan–Meier analysis, log-rank testing, and Cox regression models were applied. Results: Overall, 638 patients were included. The cohort was predominantly male (96%), with a median age of 70 years. At 30 days, one death (0.2%) and seven MACEs (1.1%) occurred. Postoperative therapy was not associated with 30-day primary patency or MACEs. At a median follow-up of 30 months, overall survival was 90.3%. Kaplan–Meier analysis showed comparable overall survival across antithrombotic regimens, with a significant difference only between patients receiving combined antiplatelet and anticoagulant therapy and those receiving other regimens. No differences emerged between vitamin K antagonists (VKA) and direct oral anticoagulants (DOAC), nor between single or dual antiplatelet therapy and anticoagulation. Multivariable Cox regression showed combined therapy was associated with poorer overall survival (HR 0.77). Primary and secondary patency were also similar among regimens except for combined therapy. Conclusions: Postoperative medical therapy was not associated with 30-day outcomes. During long-term follow-up, overall survival and graft patency were lower in patients receiving combined anticoagulant and antiplatelet therapy.
- 12 May 2026
- Published by MDPI AG in Preprints.org
Open AccessImpact of Postoperative Antithrombotic Treatment on Patency and Survival After Open Posterior Popliteal Artery Aneurysm Repair: A Multicenter Retrospective Cohort Analysis from the PARADE Study
Background/Objectives: This study assessed the impact of different postoperative antithrombotic strategies on graft patency and overall survival after open posterior repair of popliteal artery aneurysms (PAAs). Methods: A retrospectively maintained dataset of consecutive PAAs electively treated in 40 centers between January 2010 and December 2023 was analyzed. The study included patients undergoing elective open posterior repair. Primary outcomes were primary patency and overall survival according to postoperative antiplatelet or anticoagulant therapy. Secondary outcomes included secondary patency and major adverse cardiovascular events (MACEs). Kaplan–Meier analysis, log-rank testing, and Cox regression models were applied. Results: Overall, 638 patients were included. The cohort was predominantly male (96%), with a median age of 70 years. At 30 days, one death (0.2%) and seven MACEs (1.1%) occurred. Postoperative therapy was not associated with 30-day primary patency or MACEs. At a median follow-up of 30 months, overall survival was 90.3%. Kaplan–Meier analysis showed comparable overall survival across antithrombotic regimens, with a significant difference only between patients receiving combined antiplatelet and anticoagulant therapy and those receiving other regimens. No differences emerged between vitamin K antagonists (VKA) and direct oral anticoagulants (DOAC), nor between single or dual antiplatelet therapy and anticoagulation. Multivariable Cox regression showed combined therapy was associated with poorer overall survival (HR 0.77). Primary and secondary patency were also similar among regimens except for combined therapy. Conclusions: Postoperative medical therapy was not associated with 30-day outcomes. During long-term follow-up, overall survival and graft patency were lower in patients receiving combined anticoagulant and antiplatelet therapy.
- Open Access
NornirNet: A Deep Learning Framework to Distinguish Benign from Malignant Type II Endoleaks After Endovascular Aortic Aneurysm Repair Using Preoperative Imaging
Background/Objectives: Type II endoleak (T2EL) remains the most frequent complication after endovascular aortic aneurysm repair (EVAR), with uncertain clinical relevance and management. While most resolve spontaneously, persistent T2ELs can lead to sac enlargement and rupture risk. This study proposes a deep learning framework for preoperative prediction of T2EL occurrence and severity using volumetric computed tomography angiography (CTA) data. Methods: A retrospective analysis of 277 patients undergoing standard EVAR (2010–2023) was performed. Preoperative CTA scans were processed for volumetric normalization and fed into a 3D convolutional neural network (CNN) trained to classify patients into three categories: no T2EL, benign T2EL, or malignant T2EL. The model was trained on 175 cases, validated on 72, and tested on an independent cohort of 30 patients. Performance metrics included accuracy, precision, recall, F1-score, and area under the receiver operating characteristic curve (AUC). Results: The CNN achieved an overall accuracy of 76.7% (95% CI: 0.63–0.90), a macro-averaged F1-score of 0.77, and an AUC of 0.93. Class-specific AUCs were 0.93 for no T2EL, 0.91 for benign, and 0.96 for malignant cases, confirming high discriminative capacity across outcomes. Most misclassifications occurred between adjacent categories. Conclusions: This study introduces the first end-to-end 3D CNN capable of predicting both the presence and severity of T2EL directly from preoperative CTA, without manual segmentation or handcrafted features. These findings suggest that preoperative imaging encodes latent structural information predictive of endoleak-driven sac reperfusion, potentially enabling personalized pre-emptive embolization strategies and tailored surveillance after EVAR.
Open AccessNornirNet: A Deep Learning Framework to Distinguish Benign from Malignant Type II Endoleaks After Endovascular Aortic Aneurysm Repair Using Preoperative Imaging
Background/Objectives: Type II endoleak (T2EL) remains the most frequent complication after endovascular aortic aneurysm repair (EVAR), with uncertain clinical relevance and management. While most resolve spontaneously, persistent T2ELs can lead to sac enlargement and rupture risk. This study proposes a deep learning framework for preoperative prediction of T2EL occurrence and severity using volumetric computed tomography angiography (CTA) data. Methods: A retrospective analysis of 277 patients undergoing standard EVAR (2010–2023) was performed. Preoperative CTA scans were processed for volumetric normalization and fed into a 3D convolutional neural network (CNN) trained to classify patients into three categories: no T2EL, benign T2EL, or malignant T2EL. The model was trained on 175 cases, validated on 72, and tested on an independent cohort of 30 patients. Performance metrics included accuracy, precision, recall, F1-score, and area under the receiver operating characteristic curve (AUC). Results: The CNN achieved an overall accuracy of 76.7% (95% CI: 0.63–0.90), a macro-averaged F1-score of 0.77, and an AUC of 0.93. Class-specific AUCs were 0.93 for no T2EL, 0.91 for benign, and 0.96 for malignant cases, confirming high discriminative capacity across outcomes. Most misclassifications occurred between adjacent categories. Conclusions: This study introduces the first end-to-end 3D CNN capable of predicting both the presence and severity of T2EL directly from preoperative CTA, without manual segmentation or handcrafted features. These findings suggest that preoperative imaging encodes latent structural information predictive of endoleak-driven sac reperfusion, potentially enabling personalized pre-emptive embolization strategies and tailored surveillance after EVAR.
- Open Access
- 2 December 2025
- Published by MDPI AG in Preprints.org
NornirNet: A Deep Learning Framework to Distinguish Benign from Malignant Type II Endoleaks Using Preoperative Imaging
Background/Objectives: Type II endoleak (T2EL) remains the most frequent complication after endovascular aortic aneurysm repair (EVAR), with uncertain clinical relevance and management. While most resolve spontaneously, persistent T2ELs can lead to sac enlargement and rupture risk. This study proposes a deep learning framework for preoperative prediction of T2EL occurrence and severity using volumetric computed tomography angiography (CTA) data.Methods: A retrospective analysis of 287 patients undergoing standard EVAR (2010–2024) was performed. Preoperative CTA scans were processed for volumetric normalization and fed into a 3D convolutional neural network (CNN) trained to classify patients into three categories: no T2EL, benign T2EL, or malignant T2EL. The model was trained on 224 cases, validated on 33, and tested on an independent cohort of 30 patients. Performance metrics included accuracy, precision, recall, F1-score, and area under the receiver operating characteristic curve (AUC).Results: The CNN achieved an overall accuracy of 76.7% (95% CI: 0.63–0.90), macro-averaged F1-score of 0.77, and AUC of 0.93. Class-specific AUCs were 0.93 for no T2EL, 0.91 for benign, and 0.96 for malignant cases, confirming high discriminative capacity across outcomes. Most misclassifications occurred between adjacent categories.Conclusion: This study introduces the first end-to-end 3D CNN capable of predicting both presence and severity of T2EL directly from preoperative CTA, without manual segmentation or handcrafted features. These findings suggest that preoperative imaging encodes latent structural information predictive of endoleak-driven sac reperfusion, potentially enabling personalized pre-emptive embolization strategies and tailored surveillance after EVAR.
- 2 December 2025
- Published by MDPI AG in Preprints.org
Open AccessNornirNet: A Deep Learning Framework to Distinguish Benign from Malignant Type II Endoleaks Using Preoperative Imaging
Background/Objectives: Type II endoleak (T2EL) remains the most frequent complication after endovascular aortic aneurysm repair (EVAR), with uncertain clinical relevance and management. While most resolve spontaneously, persistent T2ELs can lead to sac enlargement and rupture risk. This study proposes a deep learning framework for preoperative prediction of T2EL occurrence and severity using volumetric computed tomography angiography (CTA) data.Methods: A retrospective analysis of 287 patients undergoing standard EVAR (2010–2024) was performed. Preoperative CTA scans were processed for volumetric normalization and fed into a 3D convolutional neural network (CNN) trained to classify patients into three categories: no T2EL, benign T2EL, or malignant T2EL. The model was trained on 224 cases, validated on 33, and tested on an independent cohort of 30 patients. Performance metrics included accuracy, precision, recall, F1-score, and area under the receiver operating characteristic curve (AUC).Results: The CNN achieved an overall accuracy of 76.7% (95% CI: 0.63–0.90), macro-averaged F1-score of 0.77, and AUC of 0.93. Class-specific AUCs were 0.93 for no T2EL, 0.91 for benign, and 0.96 for malignant cases, confirming high discriminative capacity across outcomes. Most misclassifications occurred between adjacent categories.Conclusion: This study introduces the first end-to-end 3D CNN capable of predicting both presence and severity of T2EL directly from preoperative CTA, without manual segmentation or handcrafted features. These findings suggest that preoperative imaging encodes latent structural information predictive of endoleak-driven sac reperfusion, potentially enabling personalized pre-emptive embolization strategies and tailored surveillance after EVAR.
- Open Access
- 23 April 2024
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 13 (9) , 2457
Integrating Pharmacomechanical Treatments for Pulmonary Embolism Management within a Hub-and-Spoke System in the Swiss Ticino Region
The Swiss Ticino regional pulmonary embolism response team (PERT) features direct access to various pharmacomechanical PE management options within a hub/spoke system, by integrating evidence, guidelines’ recommendations and personal experiences. This system involves a collaborative management of patients among the hospitals distributed throughout the region, which refer selected intermediate–high or high PE patients to a second-level hub center, located in Lugano at Cardiocentro Ticino, belonging to the Ente Ospedaliero Cantonale (EOC). The hub provides 24/7 catheterization laboratory activation for catheter-based intervention (CBI), surgical embolectomy and/or a mechanical support system such as extracorporeal membrane oxygenation (ECMO). The hub hosts PE patients after percutaneous or surgical intervention in two intensive care units, one specialized in cardiovascular anesthesiology, to be preferred for patients without relevant comorbidities or with hemodynamic instability and one specialized in post-surgical care, to be preferred for PE patients after trauma or surgery or with relevant comorbidities, such as cancer. From April 2022 to December 2023, a total of 65 patients were referred to the hub for CBI, including ultrasound-assisted catheter-directed thrombolysis (USAT) or large-bore aspiration intervention. No patient received ECMO or underwent surgical embolectomy.
- 23 April 2024
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 13 (9) , 2457
Open AccessIntegrating Pharmacomechanical Treatments for Pulmonary Embolism Management within a Hub-and-Spoke System in the Swiss Ticino Region
The Swiss Ticino regional pulmonary embolism response team (PERT) features direct access to various pharmacomechanical PE management options within a hub/spoke system, by integrating evidence, guidelines’ recommendations and personal experiences. This system involves a collaborative management of patients among the hospitals distributed throughout the region, which refer selected intermediate–high or high PE patients to a second-level hub center, located in Lugano at Cardiocentro Ticino, belonging to the Ente Ospedaliero Cantonale (EOC). The hub provides 24/7 catheterization laboratory activation for catheter-based intervention (CBI), surgical embolectomy and/or a mechanical support system such as extracorporeal membrane oxygenation (ECMO). The hub hosts PE patients after percutaneous or surgical intervention in two intensive care units, one specialized in cardiovascular anesthesiology, to be preferred for patients without relevant comorbidities or with hemodynamic instability and one specialized in post-surgical care, to be preferred for PE patients after trauma or surgery or with relevant comorbidities, such as cancer. From April 2022 to December 2023, a total of 65 patients were referred to the hub for CBI, including ultrasound-assisted catheter-directed thrombolysis (USAT) or large-bore aspiration intervention. No patient received ECMO or underwent surgical embolectomy.